Loading...
NPI 1316443179 · New York, NY · Diagnostic Radiology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Matthew Agee is a diagnostic radiology physician provider located in New York, New York. This profile covers 16 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Matthew Agee |
| Address | 525 E 68th St |
| City | New York |
| State | NY |
| ZIP | 10065 |
| Taxonomy | Diagnostic Radiology Physician |
| NPI Enumerated | April 2, 2018 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $740.7K |
| Medicaid | $4.3K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
16 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 400 | $860 | $342K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 230 | $410 | $94.8K |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 200 | $440 | $88.2K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 60 | $1,120 | $71.4K |
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 80 | $800 | $67.5K |
| 77080 | The provider performs an imaging procedure, called dual–energy X–ray absorptiometry (DXA), of one or more bony areas on the trunk to determine the bone mineral density (BMD) and whether the patient… | 810 | $40 | $35.7K |
| 77089 | The provider uses imaging data and software to calculate a patient’s trabecular bone score. The service includes an interpretation and report on the patient’s fracture risk. | 810 | $30 | $27.4K |
| 78306 | The provider performs a bone scan (also known as scintigraphy), a specialized nuclear medicine procedure in which the provider injects a radionuclide prior to imaging to examine the various bones of… | 90 | $30 | $3K |
| 78830 | The provider uses a nuclear imaging test called SPECT with concurrent CT imaging to localize a tumor, inflammatory process, or radioactive tracer distribution. Vascular flow and blood pool imaging… | 50 | $60 | $2.7K |
| 78195 | In this procedure, the provider uses a gamma–emitting radioactive tracer to diagnose and localize diseases of the lymphatics and lymph nodes. | 50 | $50 | $2.2K |
Showing 1–10 of 16
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
16 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| A9595 | 22 | 50 | 190 | $470 | $251.1K |
| 78815 | 33 | 330 | 80 | $690 | $116.6K |
| A9596 | 7 | 10 | 90 | $850 | $76.3K |
| A9552 | 24 | 200 | 60 | $350 | $42.8K |
| 78816 | 37 | 140 | 40 | $590 | $31.8K |
| 77089 | 2 | 30 | 180 | $30 | $7.6K |
| 77080 | 31 | 850 | 80 | $30 | $5.5K |
| 77085 | 94 | 120 | 50 | $40 | $4.1K |
| 78830 | 15 | 40 | 40 | $70 | $3.4K |
| 78306 | 21 | 170 | 20 | $70 | $3.2K |
Showing 1–10 of 16
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 40 | $100 | $4.3K |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 72 | 110 | 80 | $570 | $236.2K |
Other providers in the same ZIP code as Matthew Agee, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| The New York And Presbyterian Hospital | NY | General Acute Care Hospital | $276.3K | $207.4M |
| Memorial Hospital For Cancer And Allied Diseases | NY | General Acute Care Hospital | $0 | $135.1M |
| Rami Sartawi | NY | Vascular & Interventional Radiology Physician | $3.7M | $4.9M |
| Sherif Heiba | NY | Nuclear Medicine Physician | $1.7M | $18.5K |
| Gregory Harmon | NY | Ophthalmology Physician | $1.4M | $54.2K |
| Douglas Brylka | NY | Radiology Clinic/Center | $1.3M | $0 |
| David Fox | NY | Vascular Surgery Physician | $859K | $77.5K |
| Mark Francescone | NY | Diagnostic Radiology Physician | $824K | $6.3K |
| Lily Zou | NY | Diagnostic Radiology Physician | $714.5K | $0 |
| Sarah Choxi | NY | Anesthesiology Physician | $652.9K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.